A recall for certain lots of Curlin Intravenous Administration Sets has been issued by Moog Medical Devices Group (MMDG). Use of the affected sets may cause desanguination (blood loss), an under-delivery of prescribed medication/fluid, or a potential delay in therapy. Continued use of the affected administration sets may cause a potential risk of serious injury or death.
The REF (catalog) and lot numbers, for product sold and distributed in the U.S. between December 2011 and May 2012, that are included in the recall can be found in the FDA recall notice (see link below).
The recall was initiated as a result of the discovery of a reverse pump segment by customers and reported to Moog. To date, customer complaints have identified three out of 544,900 suspect sets manufactured for the United States.
See the FDA Recall